Broadly Neutralizing Antibodies (bnAbs) Against HIV: Overview
Broadly neutralizing antibodies (bnAbs) are immune proteins that recognize and bind conserved regions of the HIV envelope protein, blocking infection across diverse HIV strains. They develop in some long-term HIV controllers.
Notable bnAbs
- VRC01: Binds CD4 binding site; isolated from a 20+ year non-progressor; broad strain coverage.
- PG9: Binds V1/V2 glycan site; from a 10+ year non-progressor; complementary strain coverage.
- PGT121: Binds V3 glycan site; from a 15+ year non-progressor; distinct strain coverage.
Therapeutic Potential
bnAbs are under investigation for HIV treatment, prevention, and potential cure strategies due to their breadth and durability.
HIV & AIDS - Related Articles
- Understanding AIDS: Symptoms, Stages & HIV Connection
- Precision Cutting Tools and Techniques for Straight, Accurate Cuts
- Finger Warts and HIV: No Transmission Risk—Different Viruses Entirely
- Understanding HIV Progression: Viral Replication and Mutation
- Understanding Chronic HIV Infection: Treatment, Stages & Long-Term Management
- Understanding Laws Around the Transmission of HIV/AIDS
- HIV Antibody Screening of Blood Donations: ELISA Algorithm and Safety
